METHOD FOR USE OF IGF-BINDING PROTEIN FOR SELECTIVE SENSITIZATION OF TARGET CELLS IN VIVO

摘要

New methods for the treatment of human disease are provided. IGFBP-3 is administered together with a co-administered agent to subjects having diseas e, thereby alleviating the symptoms of the disease, under conditions where administration of IGFBP-3 alone at the maximum practicable dose has no measurable beneficial effect on the disease condition.